REPRIEVE Trial
Nearby clinics
02109
Boston
02109
Boston
Columbus 02109
02130
Salem
02109
Boston
02109
Remote/Telehealth, Woburn
The REPRIEVE trial will test whether statins reduce the risk of cardiovascular disease among people
09/28/2023
¿Se pregunta cómo las personas con VIH pueden proteger la salud de su corazón? ¡Únase a nosotros para un foro comunitario virtual mañana a las 11:00 a. m., hora del este! https://www.reprievetrial.org/for-participants/community-forum/
09/20/2023
We are excited to share that REPRIEVE will be hosting two Community Forums to review the primary results of REPRIEVE during the month of September! These will be held on Thursday, September 21st at 1:00 PM ET (English) and Friday, September 29th at 11:00 AM ET (Spanish).
Join us tomorrow at 1:00 PM ET to learn about REPRIEVE and what the trial's results mean for people with HIV! For more information, visit our website: https://www.reprievetrial.org/for-participants/community-forum/
09/12/2023
Thanks to lifesaving drugs, people with HIV are proudly achieving aging milestones. Now, researchers have been searching for ways to keep this community healthier in their later years. Read more in The New York Times: https://www.nytimes.com/2023/09/10/health/hiv-aging-statins.html
AIDS Clinical Trials Group National Heart, Lung, and Blood Institute (NHLBI) National Institute of Allergy and Infectious Diseases (NIAID)
07/25/2023
The REPRIEVE Trial demonstrates that pitavastatin lowers the incidence rate of heart disease events by 35% in people with HIV. Read the results in :
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection | NEJM Original Article from The New England Journal of Medicine — Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
04/11/2023
: Taking a daily statin medication has been found to reduce the excess risk of cardiovascular disease (CVD) among people living with HIV in , the first large-scale clinical trial testing a CVD preventive strategy in this population. Read the full NIH press release here:
Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds Premature heart disease and other chronic conditions have emerged as leading causes of morbidity and mortality.
Click here to claim your Sponsored Listing.
Category
Website
Address
Http://reprievetrial. Org/collaborating-sites/
Boston, MA
Dana-Farber Cancer Institute
Boston
Dana-Farber Cancer Institute is committed to providing expert, compassionate care.
Harvard Catalyst | The Harvard Clinical and Translational Science Center
1635 Tremont Street
Boston, 02120
Harvard Catalyst brings together the intellectual force, technologies, and clinical expertise of Har
Admetech Foundation: The Manogram Project
1 Boston Place
Boston, 02108
AdMeTech Foundation is a 501(c)(3) nonprofit organization, which has established the Manogram® Proj
The Mood Disorders Program at Tufts Medical Center
Boston, 02111
Please visit our program website for more information: www.tuftsmood.com
Maternal Health Task Force
Boston, 02115
The Maternal Health Task Force at Harvard's Center of Excellence in MCH serves as a global platform for maternal health evidence and resources.
MGH Infectious Diseases Clinical Research Unit
55 Fruit Street
Boston, 02114
Building a unit that facilitates clinical research to encompass community engagement while providing support to our young investigators. https://www.massgeneral.org/notices/socia...
MGHfC Infant Autism Study - GEMMA
55 Fruit Street
Boston, 02114
Genome, Environment, Microbiome, and Metabolome in Autism (GEMMA) Study
Reducing Anxiety in Very Young Children
Boston, 02114
Psychologists at Mass General Hospital are conducting a research study to see whether children's fear and shyness improve better from parent-child treatment, parent education, or m...
PTSD Treatment Mechanism Lab
150 South Huntington Street
Boston, 02130
PTSD Treatment Mechanisms Lab conducts research at the Women's Health Sciences Division at VA Boston
BWH Translational Pain Research
75 Francis Street
Boston, 02115
If you are interested in participating or learning more about our research, please contact us: